Improving Adherence to Statin Therapy Through a Medication Management Application
Improving Adherence to Statin Therapy Through a Medication Management Application (STAPP)
University Hospital, Essen
250 participants
Feb 17, 2023
INTERVENTIONAL
Conditions
Summary
Interventional study to compare standard of care vs standard of care plus the use of a medication therapy management smartphone app (mediteo m+, Mediteo GmbH, Heidelberg) in patients with atherosclerotic cardiovascular disease and indication to start high intensity statin therapy.
Eligibility
Inclusion Criteria4
- Age >18 years
- Atherosclerosis (neurovascular, cardiac or peripheral) with an indication to start a high intensity statin-therapy (equivalent to 40mg of atorvastatin or 20mg of rosuvastatin; start of statin therapy +/- 10 days of enrolment)
- Statin naivety
- LDL-C >100 mg/dl. No older than 21 days
Exclusion Criteria8
- Inability to take medication independently or to use the mediteo m+ app independently (e.g. people in need of care, people with dementia)
- Patient has no own smartphone (no device provided for this study)
- Prior drug therapy to lower LDL-C within the last 30 days
- Active cancer (defined as a diagnosis of cancer within 6 months before enrolment, any treatment for cancer within the previous 6 months, or recurrent or metastatic cancer) or other severe concomitant disease with a life expectancy of <6 months
- Use of a digital therapy management application (including mediteo or mediteo m+) within the last month
- Participation in another interventional trial
- Pregnancy
- Inability or unwillingness to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Free access to a study version of the medication management app mediteo m+ for reminders and documentation of statin therapy in addition to usual care
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05777655